Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: Swollen glands; Armpit pain; This is a spontaneous report from a contactable consumer received from the regulatory authority report number is GB-MHRA-WEBCOVID-202106021559117860-Q8GGJ. A 30-year-old male patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on 31May2021 (Lot Number: EY5456) as single dose for COVID-19 immunisation. Medical history included suspected COVID-19 from 29Dec2020 (Unsure when symptoms stopped) and tonsillitis. Patient is not enrolled in clinical trial. Concomitant medication included clarithromycin taken for tonsillitis from 27May2021 to 01Jun2021. The patient experienced swollen glands and armpit pain; both on 01Jun2021 with outcome of not recovered. The patient had positive COVID-19 virus test on unspecified date. Patient has not tested positive for COVID-19 on unspecified date in 2021 since having the vaccine. The case has been considered serious due to seriousness criterion of other medically important condition. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166